SCHEMBL6675717

SCHEMBL6675717

COc1ccc(Oc2ncc(S(=O)(=O)Nc3ccc(Cl)c(OC4CCN(C)C4)c3)cc2Br)cc1OC

nearest known ligand 0.64

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
UTS2R Q9UKP6 13/20 0.64
ERBB2 P04626 1/20 0.43
EPHA2 P29317 1/20 0.43
KDR P35968 1/20 0.43
EPHB4 P54760 1/20 0.43
LMNA P02545 2/20 0.39
MEN1 O00255 1/20 0.39
MAPT P10636 1/20 0.39
PKM P14618 1/20 0.39
KMT2A Q03164 1/20 0.39
S100A9 P06702 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
NOD2 Q9HC29 1/20 0.39
SCN1A P35498 1/20 0.38
SCN8A Q9UQD0 1/20 0.38
PLA2G7 Q13093 1/20 0.38
HTT P42858 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6675708 1.00 UTS2R (0.64) UTS2RERBB2EPHA2KDREPHB4
SCHEMBL6678338 0.93 UTS2R (0.62) UTS2RERBB2EPHA2KDREPHB4
SCHEMBL6678344 0.93 UTS2R (0.62) UTS2RERBB2EPHA2KDREPHB4
SCHEMBL6679730 0.92 UTS2R (0.58) UTS2RERBB2EPHA2KDREPHB4
SCHEMBL6679727 0.92 UTS2R (0.58) UTS2RERBB2EPHA2KDREPHB4
SCHEMBL6822522 0.90 UTS2R (0.65) UTS2R
SCHEMBL6822524 0.90 UTS2R (0.65) UTS2R
SCHEMBL6674005 0.89 UTS2R (0.58) UTS2RERBB2EPHA2KDREPHB4
SCHEMBL6674000 0.89 UTS2R (0.58) UTS2RERBB2EPHA2KDREPHB4
SCHEMBL6676981 0.88 UTS2R (0.57) UTS2RERBB2EPHA2KDREPHB4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004043463-A2 SULFONAMIDES SMITHKLINE BEECHAM CORPORATION (US) 2004-05-27 WO claimed
WO-2004043463-A2 SULFONAMIDES SMITHKLINE BEECHAM CORPORATION (US) 2004-05-27 WO disclosed